Population structure, antimicrobial resistance, and virulence factors of diabetic foot-associated Escherichia coli糖尿病患者足部相关大肠杆菌的种群结构、抗菌耐药性和毒力因子Microbiology SpectrumIF3.82026-01-010PRE
Dual production of polyhydroxyalkanoates and antibacterial/antiviral gold nanoparticlesFRONTIERS IN NANOTECHNOLOGYIF3.82023-09-072OA
A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex (vol 11, 14283, 2021)SCIENTIFIC REPORTSIF3.92022-08-190OAAI
A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortexSCIENTIFIC REPORTSIF3.92021-07-1215OAAI
Response to the Letter from Garcia-Montojo and colleagues concerning our paper entitled, Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosisACTA NEUROPATHOLOGICA COMMUNICATIONSIF5.72019-07-0310OAAI
Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosisACTA NEUROPATHOLOGICA COMMUNICATIONSIF5.72019-03-1847OAAI
Ultra-deep sequencing provides insights into the virology of hepatitis C super-infections in a case of three sequential infections with different genotypesJOURNAL OF CLINICAL VIROLOGYIF3.42015-09-016PREAI
Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5′UTRJOURNAL OF CLINICAL VIROLOGYIF3.42015-05-0119PREAI
The utility of different bioinformatics algorithms for genotypic HIV-1 tropism testing in a large clinical cohort with multiple subtypesAIDSIF3.12014-07-176OAAI
THE NEWLY AVAILABLE SEQUENCE-BASED GENOTYPING ASSAYS ARE MORE ACCURATE FOR HEPATITIS C VIRUS (HCV) GENOTYPING THAN PREVIOUS LINE-PROBE ASSAYSJOURNAL OF HEPATOLOGYIF332014-04-010PREAI
Evaluation of the Roche prototype 454 HIV-1 ultradeep sequencing drug resistance assay in a routine diagnostic laboratoryJOURNAL OF CLINICAL VIROLOGYIF3.42013-10-018PREAI
TIMING AND CHARACTERISTICS OF DRUG RESISTANCE MUTATIONS (DRMS) IN CHRONIC HEPATITIS C PATIENTS DURING AND AFTER TREATMENT WITH PROTEASE INHIBITOR THERAPY AT A SINGLE CENTREJOURNAL OF HEPATOLOGYIF332013-04-011PREAI
Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52011-04-0121OAAI
Full-length HIV-1 Gag determines protease inhibitor susceptibility within in-vitro assaysAIDSIF3.12010-07-1766OAAI
Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus AbacavirJOURNAL OF INFECTIOUS DISEASESIF4.52010-01-0149OAAI
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trialLANCETIF88.52010-01-01243OAAI
Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1JOURNAL OF VIROLOGYIF3.82009-09-1575OAAI
Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidateNEUROLOGYIF8.52008-01-22103PREAI